vs
Side-by-side financial comparison of INTRUSION INC (INTZ) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.
TScan Therapeutics, Inc. is the larger business by last-quarter revenue ($2.6M vs $1.5M, roughly 1.7× INTRUSION INC). INTRUSION INC runs the higher net margin — -190.7% vs -895.1%, a 704.3% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs -11.6%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-32.2M). Over the past eight quarters, INTRUSION INC's revenue compounded faster (14.4% CAGR vs -9.7%).
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.
INTZ vs TCRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $2.6M |
| Net Profit | $-2.8M | $-23.0M |
| Gross Margin | 74.3% | — |
| Operating Margin | -192.4% | -929.4% |
| Net Margin | -190.7% | -895.1% |
| Revenue YoY | -11.6% | 286.0% |
| Net Profit YoY | -44.4% | 35.8% |
| EPS (diluted) | $-0.15 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $2.6M | ||
| Q3 25 | $2.0M | $2.5M | ||
| Q2 25 | $1.9M | $3.1M | ||
| Q1 25 | $1.8M | $2.2M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $1.5M | $1.0M | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | $-2.8M | $-23.0M | ||
| Q3 25 | $-2.1M | $-35.7M | ||
| Q2 25 | $-2.0M | $-37.0M | ||
| Q1 25 | $-2.1M | $-34.1M | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-2.0M | $-29.9M | ||
| Q2 24 | $-2.1M | — | ||
| Q1 24 | $-1.7M | — |
| Q4 25 | 74.3% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 75.7% | — | ||
| Q4 24 | 74.9% | — | ||
| Q3 24 | 77.1% | — | ||
| Q2 24 | 76.0% | — | ||
| Q1 24 | 80.0% | — |
| Q4 25 | -192.4% | -929.4% | ||
| Q3 25 | -108.6% | -1475.6% | ||
| Q2 25 | -111.4% | -1256.6% | ||
| Q1 25 | -117.9% | -1669.7% | ||
| Q4 24 | -113.5% | — | ||
| Q3 24 | -135.5% | -3109.8% | ||
| Q2 24 | -139.2% | — | ||
| Q1 24 | -218.6% | — |
| Q4 25 | -190.7% | -895.1% | ||
| Q3 25 | -106.5% | -1422.1% | ||
| Q2 25 | -109.0% | -1201.3% | ||
| Q1 25 | -118.2% | -1571.9% | ||
| Q4 24 | -116.8% | — | ||
| Q3 24 | -136.3% | -2849.1% | ||
| Q2 24 | -141.6% | — | ||
| Q1 24 | -151.7% | — |
| Q4 25 | $-0.15 | $-0.18 | ||
| Q3 25 | $-0.10 | $-0.28 | ||
| Q2 25 | $-0.10 | $-0.28 | ||
| Q1 25 | $-0.11 | $-0.26 | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $-0.35 | $-0.25 | ||
| Q2 24 | $-0.53 | — | ||
| Q1 24 | $-0.94 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $152.4M |
| Total DebtLower is stronger | — | $32.5M |
| Stockholders' EquityBook value | $7.3M | $123.1M |
| Total Assets | $10.4M | $228.8M |
| Debt / EquityLower = less leverage | — | 0.26× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $152.4M | ||
| Q3 25 | $4.5M | $184.5M | ||
| Q2 25 | $8.4M | $218.0M | ||
| Q1 25 | $10.7M | $251.7M | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $1.1M | $271.1M | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $122.0K | — |
| Q4 25 | — | $32.5M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $32.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $30.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $7.3M | $123.1M | ||
| Q3 25 | $9.8M | $144.0M | ||
| Q2 25 | $11.6M | $176.7M | ||
| Q1 25 | $13.4M | $210.2M | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $2.6M | $229.1M | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | $10.4M | $228.8M | ||
| Q3 25 | $13.7M | $262.2M | ||
| Q2 25 | $16.4M | $298.6M | ||
| Q1 25 | $18.0M | $332.7M | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $7.4M | $348.0M | ||
| Q2 24 | $7.5M | — | ||
| Q1 24 | $5.7M | — |
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-531.0K | $-32.0M |
| Free Cash FlowOCF − Capex | $-549.0K | $-32.2M |
| FCF MarginFCF / Revenue | -37.1% | -1253.3% |
| Capex IntensityCapex / Revenue | 1.2% | 6.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | $-139.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-531.0K | $-32.0M | ||
| Q3 25 | $-3.0M | $-32.5M | ||
| Q2 25 | $-1.6M | $-33.3M | ||
| Q1 25 | $-1.7M | $-37.6M | ||
| Q4 24 | $-178.0K | — | ||
| Q3 24 | $-2.1M | $-27.9M | ||
| Q2 24 | $-2.9M | — | ||
| Q1 24 | $-1.1M | — |
| Q4 25 | $-549.0K | $-32.2M | ||
| Q3 25 | $-3.0M | $-33.9M | ||
| Q2 25 | $-1.9M | $-34.5M | ||
| Q1 25 | $-2.1M | $-39.1M | ||
| Q4 24 | $-645.0K | — | ||
| Q3 24 | $-2.1M | $-29.3M | ||
| Q2 24 | $-3.0M | — | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | -37.1% | -1253.3% | ||
| Q3 25 | -153.2% | -1349.6% | ||
| Q2 25 | -101.1% | -1123.1% | ||
| Q1 25 | -117.3% | -1801.8% | ||
| Q4 24 | -38.5% | — | ||
| Q3 24 | -140.4% | -2792.0% | ||
| Q2 24 | -202.3% | — | ||
| Q1 24 | -104.2% | — |
| Q4 25 | 1.2% | 6.7% | ||
| Q3 25 | 1.7% | 56.8% | ||
| Q2 25 | 17.8% | 41.6% | ||
| Q1 25 | 22.1% | 70.6% | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 2.2% | 130.6% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 5.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
